High expression of MMP-2 (P=1.5e−6), MMP-9 (P=0.027), and MMP-14 (P=0.00051) is predictive of lower RFS in chemotherapy treated for ER− human breast cancer patients. This evidence concerns the gene MMP2 and breast carcinoma.